Individuals with asthma had an increased risk of developing atrial fibrillation (AF) than asthma-free individuals, with those who had active or uncontrolled asthma having the highest risk, according to the HUNT* study.
New drug applications approved by US FDA as of 1 - 15 July 2018 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Over three-quarter of Singaporean patients with obstructive sleep apnoea (OSA) who were adherent and took on continuous positive airway pressure (CPAP) therapy after a 1-month CPAP trial period continued to be adherent to the therapy at 1 year, indicating that initial receptibility to CPAP is predictive of long-term adherence to the therapy, a local study finds.
Respiratory infections, particularly influenza, may increase the risk of treatment failure in children with asthma who present to emergency departments (EDs) with exacerbations, a secondary analysis of the DOORWAY* study revealed.
Persistent pulmonary hypertension of the newborn (PPHN) is a common phenomenon in infants with moderate or severe hypoxic ischaemic encephalopathy (HIE), a recent study has shown. Moreover, PPHN is linked to lung disease, sepsis and increased mortality.
Fluticasone furoate is superior to mometasone nasal spray in improving several perceived sensory attributes of allergic rhinitis patients, based on a multicentre, randomised, crossover, prospective study.